These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activities derived from established human myeloid cell lines reverse the suppression of cell line colony formation by lactoferrin and transferrin. Broxmeyer HE, Rubin BY, Berman E, Juliano L, Lu L, Hast LJ, Cooper S, Singer JW. Exp Hematol; 1986 Jan; 14(1):51-9. PubMed ID: 3455916 [Abstract] [Full Text] [Related]
4. Modulation of lymphocyte proliferation and immunoglobulin production by transferrin-gallium. Chitambar CR, Seigneuret MC, Matthaeus WG, Lum LG. Cancer Res; 1989 Mar 01; 49(5):1125-9. PubMed ID: 2537143 [Abstract] [Full Text] [Related]
5. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells. Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G. Exp Hematol; 1993 Mar 01; 21(3):432-7. PubMed ID: 8095026 [Abstract] [Full Text] [Related]
6. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S. Exp Hematol; 1995 Apr 01; 23(4):335-40. PubMed ID: 7895781 [Abstract] [Full Text] [Related]
7. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY. J Immunol; 1983 Sep 01; 131(3):1300-5. PubMed ID: 6193183 [Abstract] [Full Text] [Related]
8. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells. Ottmann OG, Pelus LM. J Immunol; 1988 Apr 15; 140(8):2661-5. PubMed ID: 3258618 [Abstract] [Full Text] [Related]
9. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1994 Aug 15; 22(9):919-23. PubMed ID: 7520394 [Abstract] [Full Text] [Related]
10. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY. J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433 [Abstract] [Full Text] [Related]
11. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells. Taniguchi S, Dai CH, Krantz SB. Exp Hematol; 1997 Mar 15; 25(3):193-8. PubMed ID: 9091293 [Abstract] [Full Text] [Related]